Creative Medical Technology Holdings, Inc. Share Price
NASDAQ: CELZ | Micro CapCreative Medical Technology Holdings, Inc. Stock Performance
Open $1.12 | Prev. Close $1.15 | Circuit Range N/A |
Day Range $1.12 - $1.18 | Year Range $0.64 - $6.09 | Volume 1,611 |
Average Traded $1.16 |
Creative Medical Technology Holdings, Inc. Share Price Today
As of 29 August 2026, Creative Medical Technology Holdings, Inc.'s share price is $1.16. The stock opened at $1.12, compared to its previous close of $1.15. During today's trading session, Creative Medical Technology Holdings, Inc.'s share price traded between $1.12 and $1.18, with an average price of $1.15. Over the past 52 weeks, the stock has recorded a high of $6.09 and a low of $0.64. In terms of performance, Creative Medical Technology Holdings, Inc.'s share price has declined by 35.91% over the last six months and is down 63.41% on a year-on-year basis.
Creative Medical Technology Holdings, Inc. Share Price Chart
Creative Medical Technology Holdings, Inc. Stock Fundamentals & Key Indicators
Market Cap $2.76M | PE Ratio (TTM) -0.46 | Dividend Yield N/A |
EPS (TTM) $-2.52 | Revenue (TTM) $6000.00 | Return On Equity (TTM) -79.78% |
Profit Margin -99916.80% | Debt to Equity 0.04 | Quarterly Earnings Growth YoY -18.82% |
Creative Medical Technology Holdings, Inc. Quarterly Profit & Loss
All figures in USD
Creative Medical Technology Holdings, Inc. Annual Profit & Loss
All figures in USD
About Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, which is in IND-enabling phase, to treat infertility as a result of premature ovarian failure; iPSCelz, which is in pre-clinical stage, a platform to make cell type in the body; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Creative Medical Technology Holdings, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.64 | $1.14 | +67.40% |
Jul 2026 | $1.32 | $0.68 | -51.70% |
Jun 2026 | $2.27 | $1.41 | -39.22% |
May 2026 | $2.23 | $2.32 | +6.18% |
Apr 2026 | $1.99 | $2.19 | +6.07% |
Mar 2026 | $1.85 | $2.06 | +13.81% |
Feb 2026 | $1.93 | $1.81 | -7.65% |
Jan 2026 | $2.04 | $1.96 | +1.55% |
Dec 2025 | $2.67 | $1.93 | -28.25% |
Nov 2025 | $3.16 | $2.69 | -14.06% |
Oct 2025 | $3.15 | $3.13 | -5.44% |
Sep 2025 | $3.19 | $3.31 | +4.42% |
CELZ Share Price FAQs
What is Creative Medical Technology Holdings, Inc. share price today?
What is the 52 week high and 52 week low of Creative Medical Technology Holdings, Inc. stock?
What is CELZ's market capitalisation today?
What is CELZ's net income for the last quarter?
What is the 5 year returns of CELZ?
What is the high & low stock price of CELZ today?
Can I buy CELZ shares in India?